AJP - Lung AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 288: L585-L595, 2005; doi:10.1152/ajplung.00305.2004
1040-0605/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, H. M.
Right arrow Articles by Marsh, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, H. M.
Right arrow Articles by Marsh, C. B.

INVITED REVIEW

Toward functional proteomics of alveolar macrophages

Haifeng M. Wu,1,2,3 Ming Jin,1 and Clay B. Marsh2,3

Departments of 1Pathology and 3Internal Medicine, 2Heart and Lung Research Institutes, Ohio State University College of Medicine and Public Health, Columbus, Ohio

Alveolar macrophages (AM) belong to a phenotype of macrophages with distinct biological functions and important pathophysiological roles in lung health and disease. The molecular details determining AM differentiation from blood monocytes and AM roles in lung homeostasis are largely unknown. With the use of different technological platforms, advances in the field of proteomics have made it possible to search for differences in protein expression between AM and their precursor monocytes. Proteome features of each cell type provide new clues into understanding mononuclear phagocyte biology. In-depth analyses using subproteomics and subcellular proteomics offer additional information by providing greater protein resolution and detection sensitivity. With the use of proteomic techniques, large-scale mapping of phosphorylation differences between the cell types have become possible. Furthermore, two-dimensional gel proteomics can detect germline protein variants and evaluate the impact of protein polymorphisms on an individual's susceptibility to disease. Finally, surface-enhanced laser desorption and ionization (SELDI) time-of-flight mass spectrometry offers an alternative method to recognizing differences in protein patterns between AM and monocytes or between AM under different pathological conditions. This review details the current status of this field and outlines future directions in functional proteomic analyses of AM and monocytes. Furthermore, this review presents viewpoints of integrating proteomics with translational topics in lung diseases to define the mechanisms of disease and to uncover new diagnostic and therapeutic targets.

monocytes; chronic obstructive pulmonary disease; phosphoproteomics; protein polymorphism; subproteomics



Address for reprint requests and other correspondence: H. M. Wu, Dept. of Pathology, Ohio State Univ. College of Medicine and Public Health, 288 Medical Research Facility, 420 W. 12th Ave., Columbus, OH 43210 (E-mail: wu-6{at}medctr.osu.edu




This article has been cited by other articles:


Home page
ChestHome page
R. P. Bowler, M. C. Ellison, and N. Reisdorph
Proteomics in pulmonary medicine.
Chest, August 1, 2006; 130(2): 567 - 574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Agostini and M. Facco
The promising future of proteomics in sarcoidosis.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1053 - 1054.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.